Professor of Radiation Oncology, Emory University School of Medicine
Radiation Oncology
Dr. Jonathan J. Beitler, MD
|
|
Give Review
Jonathan J. Beitler is an expert in the field of Radiation Oncology. He received awards:"America's Top Doctors", "Atlanta Magazine: Top Doctors", "America's Top Doctors for Cancer", "Top Doctors: New York Metro Area" and "Super Doctor". Jonathan Beitler is a published MD. He published 99 publications, including: 'The effect of nonporous PTFE-covered stents on intimal hyperplasia following balloon arterial injury in minipigs.' He accepts Medicare.
Publications
- ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.
- Is there a role for PET/CT parameters to differentiate thyroid cartilage invasion from penetration?
- Implementation of a Novel Surveillance Template for Head and Neck Cancer: Neck Imaging Reporting and Data System (NI-RADS).
- Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy.
- Human Papillomavirus-Related Oropharyngeal Cancer: Agree With a New Staging System, but the Devil Is in the Details.
- Quantitative Ultrasonic Nakagami Imaging of Neck Fibrosis After Head and Neck Radiation Therapy.
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage I...
- Automated Segmentation of the Parotid Gland Based on Atlas Registration and Machine Learning: A Longitudinal MRI Study in Head-and-Neck Radiation Therapy.
- Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck.
- A model and nomogram to predict tumor site origin for squamous cell cancer confined to cervical lymph nodes.
- Current treatment of T1N0 squamous cell carcinoma of the glottic larynx.
- In Regard to Chen et al.
- Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cance...
- Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): a systematic review.
- Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522.
- In Reply to Branstetter et al.
- ACR Appropriateness Criteria® thyroid carcinoma.
- Final Results of Local-Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer.
- Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study.
- Lymph node ratio influences risk of head and neck cancer loco-regional recurrence after initial surgical resection: Implications for adjuvant therapy.
- When is chemotherapy in head and neck squamous cell carcinoma not indicated?
- Ultrasonic Nakagami-parameter characterization of parotid-gland injury following head-and-neck radiotherapy: A feasibility study of late toxicity.
- Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection.
- Accuracy of Computed Tomography for Predicting Pathologic Nodal Extracapsular Extension in Patients With Head-and-Neck Cancer Undergoing Initial Surgical Resection.
- 25-Year Follow-up of HIV-positive Patients with Benign Lymphoepithelial Cysts of the Parotid Glands: A Retrospective Review.
- Radiofrequency ablation in advanced head and neck cancer.
- Acetylated Tubulin (AT) as a Prognostic Marker in Squamous Cell Carcinoma of the Head and Neck.
- Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results Data, 1973 to 2009.
- ACR Appropriateness Criteria(®) Treatment of Stage 1 T1 Glottic Cancer.
- Pilot Study of the Utility of the Synthetic PET Amino-Acid Radiotracer Anti-1-Amino-3-[(18)F]Fluorocyclobutane-1-Carboxylic Acid for the Noninvasive Imaging of Pulmona...
- Reply, Contralateral irradiation for T(limited) N2bM0 lateralized tonsil cancer.
- Laryngeal tumor volume as a predictor for thyroid cartilage penetration.
- Introduction to the imaging and staging of cancer.
- Pitfalls in the staging of cancer of the laryngeal squamous cell carcinoma.
- Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and n...
- Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7...
- Radiofrequency ablation of advanced head and neck cancer.
- ACR Appropriateness Criteria(®) Retreatment of Recurrent Head and Neck Cancer After Prior Definitive Radiation Expert Panel on Radiation Oncology-Head and N...
- Patterns of extralaryngeal spread of laryngeal cancer: Thyroid Cartilage Penetration Occurs in a Minority of Patients with Extralaryngeal Spread of Laryngeal Squamous ...
- American College of Radiology Appropriateness Criteria.
- The Negative Effect of Triple-Negative Breast Cancer on Outcome after Breast-Conserving Therapy.
- Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles.
- Assessing for primary oropharyngeal or nasopharyngeal squamous cell carcinoma from fine needle aspiration of cervical lymph node metastases.
- Prognostic accuracy of computed tomography findings for patients with laryngeal cancer undergoing laryngectomy.
- ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomas.
- Health literacy and health care in an inner-city, total laryngectomy population.
- Seduction by induction?
- High-dose-rate brachytherapy plus neck dissection for nodal disease.
- Phase II clinical trial of parenteral hydroxyurea and hyper-fractionated, accelerated external beam radiation therapy in patients with advanced squamous cell carcinoma...
- Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years.
- Maybe one drug does not fit all.
- Unusual sites of malignancies: CASE 1. Small-cell carcinoma of the hypopharynx.
- Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma.
- Mirror, mirror on the wall--which is the greatest predictive assay of them all?
- Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma.
- Controversies in management of the neck in head and neck cancer.
- Loss of cervical spinal curvature during radiotherapy for head-and-neck cancers: the neck moves, too.
- Inhibitory effect of brachytherapy on intimal hyperplasia in arteriovenous fistula.
- Transoral laser excision for early glottic cancer.
- In regard to hyperfractionation for non-small-cell lung cancer: fire, ready, aim!
- Radiation therapy for the salvage of unresectable subungual squamous cell carcinoma.
- Let's accelerate the PET learning curve.
- Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets.
- Phase I clinical trial of parenteral hydroxyurea in combination with pelvic and para-aortic external radiation and brachytherapy for patients with advanced squamous ce...
- Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension.
- A customized orofacial brachytherapy carrier: a clinical report.
- Current trends in initial management of laryngeal cancer: the declining use of open surgery.
- Adjuvant high dose rate brachytherapy (Ir-192) in the management of keloids which have recurred after surgical excision and external radiation.
- ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck.
- Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and en...
- Improved dose homogeneity in scalp irradiation using a single set-up point and different energy electron beams.
- Stage 4 squamous cell carcinoma of the tongue in a child: complete response to chemoradiotherapy.
- Weekend warriors.
- Methods of bolusing the tracheostomy stoma.
- Cosmetic control of parotid gland hypertrophy using radiation therapy.
- Moving brachytherapy from art to science.
- Esthesioneuroblastoma: is there a role for elective neck treatment?
- Ocular melanoma: total dose and dose rate effects with Co-60 plaque therapy.
- Low-dose radiotherapy for multicystic benign lymphoepithelial lesions of the parotid gland in HIV-positive patients: long-term results.
- Audiological findings in a Phase I protocol investigating the effect of WR 2721, high-dose cisplatin and radiation therapy in patients with locally advanced cervical c...
- Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas.
- Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
- New barriers to ventricular invasion in paraglottic laryngeal cancer.
- Pilot trial of cisplatin, radiation, and WR2721 in carcinoma of the uterine cervix: a New York Gynecologic Oncology Group study.
- Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology Group.
- Phase II trial of chemotherapy, external and intraluminal radiation plus surgery for oesophageal cancer.
- Phase II clinical trial with 5-fluorouracil, recombinant interferon-alpha-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esopha...
- The potential role of amifostine in conjunction with cisplatin in the treatment of locally advanced carcinoma of the cervix.
- Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24.
- Pelvic exenteration for cervix cancer: would additional intraoperative interstitial brachytherapy improve survival?
- Parotid gland tumors: a comparison of postoperative radiotherapy techniques using three dimensional (3D) dose distributions and dose-volume histograms (DVHS).
- Close or positive margins after surgical resection for the head and neck cancer patient: the addition of brachytherapy improves local control.
- XRT for stage IV Hodgkin's disease? Less chaff please.
- A phase I clinical trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced ...
- The effect of nonporous PTFE-covered stents on intimal hyperplasia following balloon arterial injury in minipigs.
- Re: Estape et al.: Close vaginal margins as a prognostic factor after radical hysterectomy.
- The relationship between dose heterogeneity ("hot" spots) and complications following high-dose rate brachytherapy.
- Pharyngeal transport dysfunction consequent to an organ-sparing protocol.
Schools
Med Coll Of Pa
Downstate Med Center
Meml Sloan Kettering Canc C
Lehigh University
Doctors Specialties
- Radiation Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Choice HMO
- Blue Choice Option POS
- Blue Open Access POS
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- Choice Care PPO
- Preferred PPO
- Kaiser Permanente
- Mail Handlers Benefit Plan (MHBP)
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Freedom Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Awards
- America's Top Doctors
- Atlanta Magazine: Top Doctors
- America's Top Doctors for Cancer
- Top Doctors: New York Metro Area
- Super Doctor
Education
-
Memorial Sloan-Kettering Cancer Center -
SUNY Health Science Center at Brooklyn
Hospital
-
Emory University Hospital -
Emory University Hospital Midtown -
Grady Memorial Hospital
Drug Facts
| NPI NUMBER | 1265536635 | |
| NPPES Provider LastName | BEITLER | |
| NPPES Provider FirstName | JONATHAN | |
| NPPES Provider ZIPCode | 303221013 | |
| NPPES Provider State | GA | |
| Specialty Description | Diagnostic Radiology | |
| Total Claim Count | 80.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 25.0 | |
| Percent Opioid Claims | 31.25 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1265536635 |
| Last Name Of The Provider | BEITLER |
| First Name Of The Provider | JONATHAN |
| View All |
Similar Doctors
|
|
Dr. Shannon T. Kahn, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristin A. Higgins, MD |
|
|
Dr. Frederick P. Schwaibold, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelly T. Drake, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hasan H. Danish, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William A. Hall, MD |
|
|
Dr. Raj S. Rajpara, MD |
|
|
Dr. Peter Johnstone, MD
This Doctor is OpenDoctor Recommended.
|